April 23, 2015
Interim report January-March 2015
Media
April 22, 2015
Aerocrine: Sales start of NIOX VERO® in Japan
April 22, 2015
New 24-week clinical study strengthens the evidence of the therapeutic value of Zubsolv for maintenance treatment of opioid dependence
April 22, 2015
Nordic Nanovector ASA – Stabilisation notice and exercise of over-allotment option, total gross proceeds from IPO increase to NOK 575 million
April 22, 2015
Orexo to present at 2015 Nordic Life Sciences Conference
April 16, 2015
WILSON THERAPEUTICS ANNOUNCES PRESENTATION OF WTX101-201 PHASE 2 STUDY AT THE EASL 50TH INTERNATIONAL LIVER CONGRESS 2015
April 16, 2015
Changes in Aerocrine’s Executive Leadership Team
April 15, 2015
BONESUPPORT CLOSES $14 MILLION IN FUNDING LED BY MAJOR SCANDINAVIAN PENSION FUND
April 15, 2015
Report from Orexo AB’s annual general meeting, 15 April 2015
April 14, 2015
INDUSTRIFONDEN JOINS GLIONOVA SEK 42 MILLION ($5.7 MILLION) FINANCING CO-LED BY HEALTHCAP AND NOVO